Production (Stage)
Beta Bionics, Inc.
BBNX
$14.43
-$1.08-6.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | -58.25% | -- | 33.95% | ||
| Total Depreciation and Amortization | 14.18% | -- | 3.49% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 122.36% | -- | -63.08% | ||
| Change in Net Operating Assets | -99.57% | -- | -762.37% | ||
| Cash from Operations | -39.89% | -- | -91.33% | ||
| Capital Expenditure | 40.64% | -- | -29.71% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -514.37% | -- | 111.54% | ||
| Cash from Investing | -503.88% | -- | 110.98% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 555,476.32% | -- | -33.33% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 271.09% | -- | -33.33% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -7.17% | -- | 94.08% | ||